Sulfur8 Medicated Anti-Dandruff Conditioner Recalled for pH Specification Failure
J. Strickland and Co is recalling Sulfur8 Medicated Anti-Dandruff Conditioner because the product pH failed to meet specifications.
What this means for you
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The recall is classified as FDA Class III, which by definition is unlikely to cause adverse health consequences, and the issue is a documentation/specification failure rather than a direct physical hazard.
Plain-English summary
J. Strickland and Co is recalling Sulfur8(R) Medicated Anti-Dandruff Conditioner, Dandruff Treatment for Braids, 12 FL OZ (356ml) spray bottles. The recall involves 1,506 cases (12 bottles per case) of Lot 13TG. The product is distributed nationwide and internationally to the Bahamas and Jamaica.
The recall was initiated because the product failed to meet its pH specification. A pH test value of 5.72 was recorded, which did not meet the required product specification range of 6.0 to 7.5.
Consumers who have purchased this product should stop using it and contact the manufacturer for further instructions.
The recalled product
- Product
- sulfur8(R) medicated anti-dandruff conditioner, dandruff treatment for Braids, spray, Active Ingredient: Salicylic Acid, 2%, 12 FL OZ (356ml) spray bottle, OTC, Made in the U.S.A. J. Strickland & Co., OLIVE BRANCH, MS 38654 UPC: 0 7561044510 7
- Manufacturer
- J. Strickland and Co
- Category
- Drug — OTC Topical
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- Lot number: 13TG
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · J. Strickland and Co
See all →- LowJ. Strickland Recalls Subpotent Sulfur8 Anti-Dandruff Conditioner
FDA (Drugs) · 2016-03-09
Same hazard · ph failure
See all →- ModerateDiclofenac topical gel recalled after failing pH specifications
FDA (Drugs) · 2026-01-28
- LowFerring Recalls Menopur Due to Out-of-Specification pH in Diluent
FDA (Drugs) · 2021-03-17
- SevereAuroMedics Recalls Acetaminophen Injection Due to Discoloration and pH Failures
FDA (Drugs) · 2021-02-10
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-12-23
- ModerateHikma Recalls Sodium Chloride Injection Vials Due to pH Failures
FDA (Drugs) · 2020-11-25